It has been demonstrated to interact with Toll-like receptor 2 (TLR2) and slightly promote glucagon-like peptide-1 (GLP-1) production via L cells, thereby enhancing intestinal microecology and improving metabolic outcomes in murine models of obesity and diabetes (30, 90). The gene discussed is TLR2; the disease is obesity disorder.